Critical Reviews in Oral Biology & Medicine, Vol 6, 132-146, Copyright © 1995 by International & American Associations for Dental Research

ARTICLES

Complement biosynthesis in the central nervous system

S. R. Barnum
Department of Microbiology, University of Alabama at Birmingham 35294, USA.

Complement is an important effector arm of the human immune response. Binding of proteolytic fragments derived from activation of complement by specific receptors leads to responses as diverse as inflammation, opsonization, and B-cell activation. The importance of characterizing the expression and regulation of complement in the CNS is highlighted by growing evidence that complement plays a significant role in the pathogenesis of a variety of neurological diseases, such as multiple sclerosis and Alzheimer's disease. In vitro studies have demonstrated that astrocytes, the predominant glial cell type in the brain, are capable of expressing or producing a majority of the components of the complement system. Expression of many complement proteins synthesized by astrocytes is regulated by both pro- and anti-inflammatory cytokines, many of which are also produced by several cell types in the CNS. In addition to astrocytes, ependymal cells, endothelial cells, microglia, and neurons have recently been shown to synthesize various complement proteins or express complement receptors on their cell surfaces. Together, these studies demonstrate that several cell types throughout the brain have the potential to express complement and, in many cases, increase expression in response to mediators of the acute phase response. These studies suggest that complement may play a greater role in CNS immune responses than previously thought, and pave the way for better understanding of the dynamics of complement expression and regulation in vivo. Such understanding may lead to therapeutic manipulation of complement host defense functions in a variety of inflammatory and degenerative diseases in the CNS.

This article has been cited by other articles:

				J. Wang, K. Ohno-Matsui, T. Yoshida, A. Kojima, N. Shimada, K.-i. Nakahama, O. Safranova, N. Iwata, T. C. Saido, M. Mochizuki, et al. Altered Function of Factor I Caused by Amyloid {beta}: Implication for Pathogenesis of Age-Related Macular Degeneration from Drusen J. Immunol., July 1, 2008; 181(1): 712 - 720. [Abstract] [Full Text] [PDF]

				E. C. Johnson, L. Jia, W. O. Cepurna, T. A. Doser, and J. C. Morrison Global Changes in Optic Nerve Head Gene Expression after Exposure to Elevated Intraocular Pressure in a Rat Glaucoma Model Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3161 - 3177. [Abstract] [Full Text] [PDF]

				R P Lisak, J A Benjamins, B Bealmear, B Yao, S Land, L Nedelkoska, and D Skundric Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures Multiple Sclerosis, April 1, 2006; 12(2): 149 - 168. [Abstract] [PDF]

				E. Alberdi, M. V. Sanchez-Gomez, I. Torre, M. Domercq, A. Perez-Samartin, F. Perez-Cerda, and C. Matute Activation of kainate receptors sensitizes oligodendrocytes to complement attack. J. Neurosci., March 22, 2006; 26(12): 3220 - 3228. [Abstract] [Full Text] [PDF]

				P. J. G. Zwijnenburg, T. van der Poll, J. J. Roord, and A. M. van Furth Chemotactic Factors in Cerebrospinal Fluid during Bacterial Meningitis Infect. Immun., March 1, 2006; 74(3): 1445 - 1451. [Full Text] [PDF]

				M. R. D'Andrea Evidence that immunoglobulin-positive neurons in Alzheimer's disease are dying via the classical antibody-dependent complement pathway American Journal of Alzheimer's Disease and Other Dementias, May 1, 2005; 20(3): 144 - 150. [Abstract] [PDF]

				R. R. de Jonge, I. N. van Schaik, J. P. Vreijling, D. Troost, and F. Baas Expression of complement components in the peripheral nervous system Hum. Mol. Genet., February 1, 2004; 13(3): 295 - 302. [Abstract] [Full Text] [PDF]

				R. M. Cowell, J. M. Plane, and F. S. Silverstein Complement Activation Contributes to Hypoxic-Ischemic Brain Injury in Neonatal Rats J. Neurosci., October 15, 2003; 23(28): 9459 - 9468. [Abstract] [Full Text] [PDF]

				S. H. Weerth, H. Rus, M. L. Shin, and C. S. Raine Complement C5 in Experimental Autoimmune Encephalomyelitis (EAE) Facilitates Remyelination and Prevents Gliosis Am. J. Pathol., September 1, 2003; 163(3): 1069 - 1080. [Abstract] [Full Text] [PDF]

				S. K. Singhrao, J. W. Neal, N. K. Rushmere, B. P. Morgan, and P. Gasque Spontaneous Classical Pathway Activation and Deficiency of Membrane Regulators Render Human Neurons Susceptible to Complement Lysis Am. J. Pathol., September 1, 2000; 157(3): 905 - 918. [Abstract] [Full Text] [PDF]

				K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Up-Regulated Production and Activation of the Complement System in Alzheimer's Disease Brain Am. J. Pathol., March 1, 1999; 154(3): 927 - 936. [Abstract] [Full Text] [PDF]

				S. C. Makrides Therapeutic Inhibition of the Complement System Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88. [Abstract] [Full Text] [PDF]

				A. VERKHRATSKY, R. K. ORKAND, and H. KETTENMANN Glial Calcium: Homeostasis and Signaling Function Physiol Rev, January 1, 1998; 78(1): 99 - 141. [Abstract] [Full Text] [PDF]

				T. Moller, C. Nolte, R. Burger, A. Verkhratsky, and H. Kettenmann Mechanisms of C5a and C3a Complement Fragment-Induced [Ca2+]i Signaling in Mouse Microglia J. Neurosci., January 15, 1997; 17(2): 615 - 624. [Abstract] [Full Text] [PDF]